Dr. Bernhard Hampl joins ChemWerth Board of Directors

23-Oct-2009 - USA

Peter Werth, the President and CEO of US-based ChemWerth Inc, announced that Dr. Bernhard Hampl has joined the company’s board of directors.

Dr. Hampl, received his Ph.D. in pharmaceutical chemistry from Ludwig-Maximillians University in Munich and his career has included working for Cyanamid GmbH where he served as the company's director of research and development and technical director; Chief Executive Officer of Eon Labs; and, President and CEO of Sandoz U.S. While CEO of Sandoz, Dr. Hampl also served as a member of the Executive Board of the Generic Pharmaceutical Association, especially advocating a pathway to the approval and future use of bio-generics.

Other news from the department people

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance